Table 1. Clinical characteristics of the study population (n=118).
| Category | Control group (n=59) | TAVR group (n=59) |
|---|---|---|
| Age (years), mean ± SD | 71.1±9.1 | 76.2±8.1 |
| Sex, n (%) | ||
| Female | 20 (33.9) | 24 (40.7) |
| Male | 39 (66.1) | 35 (59.3) |
| Aortic valve disease, n (%) | ||
| AS | – | 55 (93.2) |
| AR | – | 4 (6.8) |
| Aortic valve classification, n (%) | ||
| TAV | 59 (100.0) | 47 (79.7) |
| BAV | 0 | 12 (20.3) |
| Aortic annulus diameter, n (%) | ||
| D ≤19 mm | 1 (1.7) | 0 |
| 19 mm < D ≤29 mm | 57 (96.6) | 56 (94.9) |
| 29 mm < D | 1 (1.7) | 3 (5.1) |
| AAo mean diameter, n (%) | ||
| AAo ≤40 mm | 59 (100.0) | 45 (76.3) |
| 40 mm < AAo ≤50 mm | 0 | 13 (22.0) |
| 50 mm < AAo | 0 | 1 (1.7) |
TAVR, transcatheter aortic valve replacement; SD, standard deviation; AS, aortic valve stenosis; AR, aortic regurgitation; TAV, tricuspid aortic valve; BAV, bicuspid aortic valve (without raphe); D, diameter; AAo, ascending aorta.